Histological study of human dental alveols treated with xeno-graft in implantology

Autores
Jammal, María Victoria; Juárez, Jorge Nicolás; Schemberger, Viviana Elizabeth; Diaz, Silvana; Garcia, Jorge; Missana, Liliana Raquel
Año de publicación
2021
Idioma
inglés
Tipo de recurso
documento de conferencia
Estado
versión publicada
Descripción
Dental implants are the treatment to replace missing teeth. The success of this therapy is achieved if the existing bone is sufficient to surround and stabilize the implant. While, when it is not, the application of a bone graft or substitute is essential. The most widely used is the autograft or autologous bone due to its biocompatibility. However, the market offers other variants, such as bovine bone xenografts that are used in daily practice. The objective of this study was to evaluate 3 bovine xenografts (BIOSS, TIOSS and SYNERGY) applied to alveoli after human extraction during prosthetic rehabilitation with implants. Bone tissue samples were treated with: Group 1, TIOSS; Group 2, BIOSS; Group 3, Synergy; Group 4, without substitute (clot). Histopathological studies were carried out. The interpretation of bone biopsies was made following ISO Standards 10993-6 Year 2007: A- Biocompatibility: inflammation, foreign body reaction (FBR), abscesses, necrosis, fibrosis, macrophages. B- Bone neoformation: type of bone, presence/absence of particles, and rate of resorption. Histometric and statistical studies. The histological results obtained at 4 months were: (A) Biocompatibility: Group 1 – TIOSS: moderate chronic inflammation. Presence of FBR, abundant lymphocytes. Group 2 and 3 – BIOSS and Synergy similar behavior with a few chronic inflammation and absence of FBR. Group 4 (clot) – absence of FBR. None of the cases presented necrosis and/or abscesses. (B Bone neoformation: Group 1 – TIOSS: amorphous particles surrounded by numerous congestive vessels and predominantly lax connective tissue and newly composed bone (38%). Group 2 and 3 – BIOSS and Synergy: particles surrounded by fibrovascularized tissue and newly composed bone (47% BIOSS and 49% Synergy) with abundant fatty bone marrow. Group 4 (clot) – laminar bone type (45%). New bone percentages did not show statistically significant differences (P = 0.2). The reabsorption rate of the particles was low in the 3 substitutes evaluated by their persistence at 4 months post placement in the alveolus. From the results obtained, we conclude that BIOSS and Synergy had better biological behavior due to the absence of FBR. All three stimulated bone neoformation. The low reabsorption rate prevented alveolar bone atrophy after extraction and maintained the dimensions of the receptor zone; beneficial events for the stability of the implant and its osseo integration.
Fil: Jammal, María Victoria. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina
Fil: Juárez, Jorge Nicolás. No especifíca;
Fil: Schemberger, Viviana Elizabeth. No especifíca;
Fil: Diaz, Silvana. Universidad del Salvador; Argentina
Fil: Garcia, Jorge. Universidad del Salvador; Argentina
Fil: Missana, Liliana Raquel. Universidad Nacional de Tucuman. Instituto de Investigaciones En Medicina Molecular y Celular Aplicada del Bicentenario. - Gobierno de la Provincia de Tucuman. Ministerio de Salud. Sistema Provincial de Salud. Instituto de Investigaciones En Medicina Molecular y Celular Aplicada del Bicentenario. - Consejo Nacional de Investigaciones Cientificas y Tecnicas. Centro Cientifico Tecnologico Conicet Noa Sur. Instituto de Investigaciones En Medicina Molecular y Celular Aplicada del Bicentenario.; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Tucumán. Planta Piloto de Procesos Industriales Microbiológicos; Argentina
IV Joint Meeting of The Biology Societies of Argentina
Mendoza
Argentina
Sociedad de Biología de Cuyo
Sociedad Argentina de Biología
Sociedad de Biología de Córdoba
Sociedad de Biología de Rosario
Asociación de Biología de Tucumán
Materia
BOVINE XENOGRAFTS
BONE REGENERATION
ALVEOLI
Nivel de accesibilidad
acceso abierto
Condiciones de uso
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
Repositorio
CONICET Digital (CONICET)
Institución
Consejo Nacional de Investigaciones Científicas y Técnicas
OAI Identificador
oai:ri.conicet.gov.ar:11336/172739
Acceder
id CONICETDig_9dee27e0e3a81fc913c82c329a217bf3
oai_identifier_str oai:ri.conicet.gov.ar:11336/172739
network_acronym_str CONICETDig
repository_id_str 3498
network_name_str CONICET Digital (CONICET)
spelling Histological study of human dental alveols treated with xeno-graft in implantologyJammal, María VictoriaJuárez, Jorge NicolásSchemberger, Viviana ElizabethDiaz, SilvanaGarcia, JorgeMissana, Liliana RaquelBOVINE XENOGRAFTSBONE REGENERATIONALVEOLIhttps://purl.org/becyt/ford/3.2https://purl.org/becyt/ford/3Dental implants are the treatment to replace missing teeth. The success of this therapy is achieved if the existing bone is sufficient to surround and stabilize the implant. While, when it is not, the application of a bone graft or substitute is essential. The most widely used is the autograft or autologous bone due to its biocompatibility. However, the market offers other variants, such as bovine bone xenografts that are used in daily practice. The objective of this study was to evaluate 3 bovine xenografts (BIOSS, TIOSS and SYNERGY) applied to alveoli after human extraction during prosthetic rehabilitation with implants. Bone tissue samples were treated with: Group 1, TIOSS; Group 2, BIOSS; Group 3, Synergy; Group 4, without substitute (clot). Histopathological studies were carried out. The interpretation of bone biopsies was made following ISO Standards 10993-6 Year 2007: A- Biocompatibility: inflammation, foreign body reaction (FBR), abscesses, necrosis, fibrosis, macrophages. B- Bone neoformation: type of bone, presence/absence of particles, and rate of resorption. Histometric and statistical studies. The histological results obtained at 4 months were: (A) Biocompatibility: Group 1 – TIOSS: moderate chronic inflammation. Presence of FBR, abundant lymphocytes. Group 2 and 3 – BIOSS and Synergy similar behavior with a few chronic inflammation and absence of FBR. Group 4 (clot) – absence of FBR. None of the cases presented necrosis and/or abscesses. (B Bone neoformation: Group 1 – TIOSS: amorphous particles surrounded by numerous congestive vessels and predominantly lax connective tissue and newly composed bone (38%). Group 2 and 3 – BIOSS and Synergy: particles surrounded by fibrovascularized tissue and newly composed bone (47% BIOSS and 49% Synergy) with abundant fatty bone marrow. Group 4 (clot) – laminar bone type (45%). New bone percentages did not show statistically significant differences (P = 0.2). The reabsorption rate of the particles was low in the 3 substitutes evaluated by their persistence at 4 months post placement in the alveolus. From the results obtained, we conclude that BIOSS and Synergy had better biological behavior due to the absence of FBR. All three stimulated bone neoformation. The low reabsorption rate prevented alveolar bone atrophy after extraction and maintained the dimensions of the receptor zone; beneficial events for the stability of the implant and its osseo integration.Fil: Jammal, María Victoria. Consejo Nacional de Investigaciones Científicas y Técnicas; ArgentinaFil: Juárez, Jorge Nicolás. No especifíca;Fil: Schemberger, Viviana Elizabeth. No especifíca;Fil: Diaz, Silvana. Universidad del Salvador; ArgentinaFil: Garcia, Jorge. Universidad del Salvador; ArgentinaFil: Missana, Liliana Raquel. Universidad Nacional de Tucuman. Instituto de Investigaciones En Medicina Molecular y Celular Aplicada del Bicentenario. - Gobierno de la Provincia de Tucuman. Ministerio de Salud. Sistema Provincial de Salud. Instituto de Investigaciones En Medicina Molecular y Celular Aplicada del Bicentenario. - Consejo Nacional de Investigaciones Cientificas y Tecnicas. Centro Cientifico Tecnologico Conicet Noa Sur. Instituto de Investigaciones En Medicina Molecular y Celular Aplicada del Bicentenario.; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Tucumán. Planta Piloto de Procesos Industriales Microbiológicos; ArgentinaIV Joint Meeting of The Biology Societies of ArgentinaMendozaArgentinaSociedad de Biología de CuyoSociedad Argentina de BiologíaSociedad de Biología de CórdobaSociedad de Biología de RosarioAsociación de Biología de TucumánTech Science Press2021info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/conferenceObjectReuniónJournalhttp://purl.org/coar/resource_type/c_5794info:ar-repo/semantics/documentoDeConferenciaapplication/pdfapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/172739Histological study of human dental alveols treated with xeno-graft in implantology; IV Joint Meeting of The Biology Societies of Argentina; Mendoza; Argentina; 2020; 36-370327-95451667-5746CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/url/https://www.techscience.com/biocell/v45nSuppl.3info:eu-repo/semantics/altIdentifier/url/https://www.biologia.org.ar/eventos/iv-reunion-conjunta-de-sociedades-de-biologia-de-la-republica-argentina/Internacionalinfo:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-10-15T15:15:01Zoai:ri.conicet.gov.ar:11336/172739instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-10-15 15:15:01.942CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse
dc.title.none.fl_str_mv Histological study of human dental alveols treated with xeno-graft in implantology
title Histological study of human dental alveols treated with xeno-graft in implantology
spellingShingle Histological study of human dental alveols treated with xeno-graft in implantology
Jammal, María Victoria
BOVINE XENOGRAFTS
BONE REGENERATION
ALVEOLI
title_short Histological study of human dental alveols treated with xeno-graft in implantology
title_full Histological study of human dental alveols treated with xeno-graft in implantology
title_fullStr Histological study of human dental alveols treated with xeno-graft in implantology
title_full_unstemmed Histological study of human dental alveols treated with xeno-graft in implantology
title_sort Histological study of human dental alveols treated with xeno-graft in implantology
dc.creator.none.fl_str_mv Jammal, María Victoria
Juárez, Jorge Nicolás
Schemberger, Viviana Elizabeth
Diaz, Silvana
Garcia, Jorge
Missana, Liliana Raquel
author Jammal, María Victoria
author_facet Jammal, María Victoria
Juárez, Jorge Nicolás
Schemberger, Viviana Elizabeth
Diaz, Silvana
Garcia, Jorge
Missana, Liliana Raquel
author_role author
author2 Juárez, Jorge Nicolás
Schemberger, Viviana Elizabeth
Diaz, Silvana
Garcia, Jorge
Missana, Liliana Raquel
author2_role author
author
author
author
author
dc.subject.none.fl_str_mv BOVINE XENOGRAFTS
BONE REGENERATION
ALVEOLI
topic BOVINE XENOGRAFTS
BONE REGENERATION
ALVEOLI
purl_subject.fl_str_mv https://purl.org/becyt/ford/3.2
https://purl.org/becyt/ford/3
dc.description.none.fl_txt_mv Dental implants are the treatment to replace missing teeth. The success of this therapy is achieved if the existing bone is sufficient to surround and stabilize the implant. While, when it is not, the application of a bone graft or substitute is essential. The most widely used is the autograft or autologous bone due to its biocompatibility. However, the market offers other variants, such as bovine bone xenografts that are used in daily practice. The objective of this study was to evaluate 3 bovine xenografts (BIOSS, TIOSS and SYNERGY) applied to alveoli after human extraction during prosthetic rehabilitation with implants. Bone tissue samples were treated with: Group 1, TIOSS; Group 2, BIOSS; Group 3, Synergy; Group 4, without substitute (clot). Histopathological studies were carried out. The interpretation of bone biopsies was made following ISO Standards 10993-6 Year 2007: A- Biocompatibility: inflammation, foreign body reaction (FBR), abscesses, necrosis, fibrosis, macrophages. B- Bone neoformation: type of bone, presence/absence of particles, and rate of resorption. Histometric and statistical studies. The histological results obtained at 4 months were: (A) Biocompatibility: Group 1 – TIOSS: moderate chronic inflammation. Presence of FBR, abundant lymphocytes. Group 2 and 3 – BIOSS and Synergy similar behavior with a few chronic inflammation and absence of FBR. Group 4 (clot) – absence of FBR. None of the cases presented necrosis and/or abscesses. (B Bone neoformation: Group 1 – TIOSS: amorphous particles surrounded by numerous congestive vessels and predominantly lax connective tissue and newly composed bone (38%). Group 2 and 3 – BIOSS and Synergy: particles surrounded by fibrovascularized tissue and newly composed bone (47% BIOSS and 49% Synergy) with abundant fatty bone marrow. Group 4 (clot) – laminar bone type (45%). New bone percentages did not show statistically significant differences (P = 0.2). The reabsorption rate of the particles was low in the 3 substitutes evaluated by their persistence at 4 months post placement in the alveolus. From the results obtained, we conclude that BIOSS and Synergy had better biological behavior due to the absence of FBR. All three stimulated bone neoformation. The low reabsorption rate prevented alveolar bone atrophy after extraction and maintained the dimensions of the receptor zone; beneficial events for the stability of the implant and its osseo integration.
Fil: Jammal, María Victoria. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina
Fil: Juárez, Jorge Nicolás. No especifíca;
Fil: Schemberger, Viviana Elizabeth. No especifíca;
Fil: Diaz, Silvana. Universidad del Salvador; Argentina
Fil: Garcia, Jorge. Universidad del Salvador; Argentina
Fil: Missana, Liliana Raquel. Universidad Nacional de Tucuman. Instituto de Investigaciones En Medicina Molecular y Celular Aplicada del Bicentenario. - Gobierno de la Provincia de Tucuman. Ministerio de Salud. Sistema Provincial de Salud. Instituto de Investigaciones En Medicina Molecular y Celular Aplicada del Bicentenario. - Consejo Nacional de Investigaciones Cientificas y Tecnicas. Centro Cientifico Tecnologico Conicet Noa Sur. Instituto de Investigaciones En Medicina Molecular y Celular Aplicada del Bicentenario.; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Tucumán. Planta Piloto de Procesos Industriales Microbiológicos; Argentina
IV Joint Meeting of The Biology Societies of Argentina
Mendoza
Argentina
Sociedad de Biología de Cuyo
Sociedad Argentina de Biología
Sociedad de Biología de Córdoba
Sociedad de Biología de Rosario
Asociación de Biología de Tucumán
description Dental implants are the treatment to replace missing teeth. The success of this therapy is achieved if the existing bone is sufficient to surround and stabilize the implant. While, when it is not, the application of a bone graft or substitute is essential. The most widely used is the autograft or autologous bone due to its biocompatibility. However, the market offers other variants, such as bovine bone xenografts that are used in daily practice. The objective of this study was to evaluate 3 bovine xenografts (BIOSS, TIOSS and SYNERGY) applied to alveoli after human extraction during prosthetic rehabilitation with implants. Bone tissue samples were treated with: Group 1, TIOSS; Group 2, BIOSS; Group 3, Synergy; Group 4, without substitute (clot). Histopathological studies were carried out. The interpretation of bone biopsies was made following ISO Standards 10993-6 Year 2007: A- Biocompatibility: inflammation, foreign body reaction (FBR), abscesses, necrosis, fibrosis, macrophages. B- Bone neoformation: type of bone, presence/absence of particles, and rate of resorption. Histometric and statistical studies. The histological results obtained at 4 months were: (A) Biocompatibility: Group 1 – TIOSS: moderate chronic inflammation. Presence of FBR, abundant lymphocytes. Group 2 and 3 – BIOSS and Synergy similar behavior with a few chronic inflammation and absence of FBR. Group 4 (clot) – absence of FBR. None of the cases presented necrosis and/or abscesses. (B Bone neoformation: Group 1 – TIOSS: amorphous particles surrounded by numerous congestive vessels and predominantly lax connective tissue and newly composed bone (38%). Group 2 and 3 – BIOSS and Synergy: particles surrounded by fibrovascularized tissue and newly composed bone (47% BIOSS and 49% Synergy) with abundant fatty bone marrow. Group 4 (clot) – laminar bone type (45%). New bone percentages did not show statistically significant differences (P = 0.2). The reabsorption rate of the particles was low in the 3 substitutes evaluated by their persistence at 4 months post placement in the alveolus. From the results obtained, we conclude that BIOSS and Synergy had better biological behavior due to the absence of FBR. All three stimulated bone neoformation. The low reabsorption rate prevented alveolar bone atrophy after extraction and maintained the dimensions of the receptor zone; beneficial events for the stability of the implant and its osseo integration.
publishDate 2021
dc.date.none.fl_str_mv 2021
dc.type.none.fl_str_mv info:eu-repo/semantics/publishedVersion
info:eu-repo/semantics/conferenceObject
Reunión
Journal
http://purl.org/coar/resource_type/c_5794
info:ar-repo/semantics/documentoDeConferencia
status_str publishedVersion
format conferenceObject
dc.identifier.none.fl_str_mv http://hdl.handle.net/11336/172739
Histological study of human dental alveols treated with xeno-graft in implantology; IV Joint Meeting of The Biology Societies of Argentina; Mendoza; Argentina; 2020; 36-37
0327-9545
1667-5746
CONICET Digital
CONICET
url http://hdl.handle.net/11336/172739
identifier_str_mv Histological study of human dental alveols treated with xeno-graft in implantology; IV Joint Meeting of The Biology Societies of Argentina; Mendoza; Argentina; 2020; 36-37
0327-9545
1667-5746
CONICET Digital
CONICET
dc.language.none.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv info:eu-repo/semantics/altIdentifier/url/https://www.techscience.com/biocell/v45nSuppl.3
info:eu-repo/semantics/altIdentifier/url/https://www.biologia.org.ar/eventos/iv-reunion-conjunta-de-sociedades-de-biologia-de-la-republica-argentina/
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
eu_rights_str_mv openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.format.none.fl_str_mv application/pdf
application/pdf
application/pdf
dc.coverage.none.fl_str_mv Internacional
dc.publisher.none.fl_str_mv Tech Science Press
publisher.none.fl_str_mv Tech Science Press
dc.source.none.fl_str_mv reponame:CONICET Digital (CONICET)
instname:Consejo Nacional de Investigaciones Científicas y Técnicas
reponame_str CONICET Digital (CONICET)
collection CONICET Digital (CONICET)
instname_str Consejo Nacional de Investigaciones Científicas y Técnicas
repository.name.fl_str_mv CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas
repository.mail.fl_str_mv dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar
_version_ 1846083297931689984
score 13.221938

Publicaciones similares